Genomics of Inflammation and Immunity
We use high-throughput genetic, genomic and multi-omic screens, plus immunological assays, to identify drug targets and deliver personalised medicine for patients with immune-mediated disease, with a particular focus on inflammatory bowel diseases (IBD).
![](https://cdn.prod.website-files.com/59f2f381831e850001600c80/59f30c51f42fff00015a1201_imageHeader.png)